Skip to Content

Coagulation factor ix Pregnancy and Breastfeeding Warnings

Coagulation factor ix is also known as: Alphanine SD, Alprolix, BeneFIX 250 Int'l Units, BeneFix, Idelvion, Ixinity, Mononine, Rebinyn, Rixubis

Medically reviewed on Dec 28, 2017

Coagulation factor ix Pregnancy Warnings

Coagulation factor IX has been assign to pregnancy category C by the FDA. Animal studies have not revealed evidence of teratogenicity. There are no controlled data in human pregnancy. Coagulation factor IX is only recommended for use during pregnancy when benefit outweighs risk.

See references

Coagulation factor ix Breastfeeding Warnings

There are no data on the excretion of coagulation factor IX into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

According to the manufacturer, Rixubis (coagulation factor IX recombinant) should be used with caution in nursing women.

See references

References for pregnancy information

  1. "Product Information. Mononine (coagulation factor IX)." CSL Behring, King of Prussia, PA.
  2. "Product Information. BeneFIX (coagulation factor IX)." Wyeth Laboratories, Philadelphia, PA.
  3. "Product Information. Alphanine SD (coagulation factor IX)." Grifols Biologicals Inc, Los Angeles, CA.

References for breastfeeding information

  1. "Product Information. BeneFIX (coagulation factor IX)." Wyeth Laboratories, Philadelphia, PA.
  2. "Product Information. Alphanine SD (coagulation factor IX)." Grifols Biologicals Inc, Los Angeles, CA.
  3. "Product Information. Mononine (coagulation factor IX)." CSL Behring, King of Prussia, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide